Results 201 to 210 of about 326,926 (265)

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023. [PDF]

J Viral Hepat
Suoh M, Esmaili S, Eslam M, George J.
europepmc   +1 more source

High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan. [PDF]

Liver Int
Khodjaeva ME, Khikmatullaeva AS, Ibadullaeva NS, Khudaykulova GK, Ilyasova MM, Eshbayeva KU, Abdurakhmanova DN, Kefalakes H, Huber P, Gebel MJ, Musabaev EI, Wedemeyer H, Sandmann L.   +12 more
europepmc   +1 more source

Identification of Marine-Derived Compounds with Potent Antiviral Activity in a Recombinant HBV cccDNA Cell Model

ACS Omega
Xinluo Song, Yuyue Ji, Mengjing Cong, Dehua Yang, Ming-Wei Wang, Junfeng Wang, Qingtong Zhou, Jieliang Chen   +7 more
doaj   +1 more source

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]

Front Immunol
Zhu C, Yang J, Sheng Y, Fang M.
europepmc   +1 more source

Chronic hepatitis D infection is associated with distinguishing microbial and functional features in the gut microbiome. [PDF]

Front Microbiol
Gewirtz MA, Zhang Y, Vaidy N, Redekar NR, Minerva N, Haddad JA, Oringher JL, Afruza R, Chakraborty M, Menkart MG, Gopalakrishna H, Hercun J, Lack J, Kleiner DE, Lionakis MS, Koh C, Heller T.   +16 more
europepmc   +1 more source

Lifetime medical costs of chronic hepatitis C in the United States. [PDF]

BMC Health Serv Res
Abimbola TO, Symum H, Van Handel M, Teshale E, Thompson W.   +4 more
europepmc   +1 more source

Cost-Effectiveness of Interventions to Improve Retention in Care for Chronic Hepatitis B in the United States. [PDF]

J Viral Hepat
Starinieri I, Chitnis A, Wong RJ, Yette E, Pham H, Tang AS, So S, Toy M.   +7 more
europepmc   +1 more source

T cell dysfunction and metabolic disruption in chronic hepatitis C virus infection. [PDF]

Front Immunol
Sajeet B, Ganapathi U, Naganathan K, Parthasarathy A, Darvin P, Sasidharan Nair V.   +5 more
europepmc   +1 more source

Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation. [PDF]

Clin Mol Hepatol
Kim GA, Choi WM, Choi GH, Kim IH, Kanto T, Yu ML, Lim YS.   +6 more
europepmc   +1 more source

Hippuric acid contributes to NK-cell activation with dependence on TLR2 in chronic hepatitis B complicated by MASLD. [PDF]

iScience
Zhang L, Li A, Xu K, Tao S, Zheng M.
europepmc   +1 more source